The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation
Zhenfang Du(Chinese University of Hong Kong), Qian Tao(Chinese University of Hong Kong)
Cited by 28
Related Papers
Mechanisms of receptor tyrosine kinase activation in cancer
|Molecular Cancer|2018|1.1k
The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer
|PLoS ONE|2012|133
Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting
|Nature Communications|2021|70